POSTER SESSION VI
Wednesday, March 21, 2012 — 1:00 PM - 4:00 PM
CC Exhibit Hall B3 & C
Click on the blue numbers in parentheses to display abstracts.
Click the button next to any title to add to Itinerary Planner...
HEMATOPATHOLOGY
Poster#
Title and Authors
Itinerary Planner
216
A Novel Small Molecule MIRA-1 Induces Cytotoxicity in Multiple Myeloma Cells Harbouring Wild-Type or Mutant p53
(1534)
MN Saha, J Jiang, H Chang - University Health Network, Toronto, Canada
Identification of Micro RNAs within Chromosome 1p Minimal Deletion Region Associated Adverse Outcomes in Multiple Myeloma
(1600)
Y Yang, Y Ning, H Chang - Univesity Health Network, Toronto, Canada; University of Maryland, Baltimore
IgM Multiple Myeloma Has Unique Attributes Distinguishing It from Other Plasma Cell Neoplasms and Lymphoplasmacytic Lymphoma
(1455)
RL King, MT Howard, JM Hodnefield, WG Morice - Mayo Clinic, Rochester, MN
CD200 Expression and Progression Free Survival in Plasma Cell Dyscrasia
(1464)
AP Laramore, W-K Chiu, CH Dunphy - University of North Carolina, Chapel Hill, NC
MDS in Association with Myeloma and MGUS
(1479)
Y-C Liu, Y Wu, S Mathew, R Niesvizky, R Pearse, A Orazi, S Ely - Weill-Cornell Medical Center, New York, NY
Plasma Cell Neoplasm Concomitant with Myeloid Malignancies: Clinicopathological Study of 7 Cases
(1528)
DM Reddi, EL Boswell, CM Lu, E Wang - Duke University Medical Center, Durham; University of California San Francisco, San Francisco
The Value of Whole Slide Imaging for Enumeration of Plasma Cells in Plasma Cell Dyscrasia
(1458)
J Kohan, SL Perkins, A Wilson, S Tripp, ME Salama - University of Utah, Salt Lake City; ARUP Institute for Clinical & Experimental Pathology, Salt Lake City
Cost-Effective, User-Friendly Proliferation and Cytogenetic Analysis in Myeloma
(1395)
S Ely, A Modin, A Rossi, O Elemento, S Shenker - Weill-Cornell Medical Center, New York, NY
Utility of Karyotype and FISH in Treated Myeloma Patients with No Morphologic Evidence of Disease
(1498)
C Mosse, A Seegmiller, A Kim, K Kressin - Vanderbilt University Medical Center, Nashville, TN; Tennessee Valley Healthcare Systems VA, Nashville, TN
Assessing Minimal Disease in Plasma Cell Neoplasms: A Comparison between Multicolor Flow Cytometry and Immunohistochemistry
(1500)
DP Ng, CS Liang, T Tian, C Yin, KH Young, JL Jorgensen, D Hoehn, R Sargent, RN Miranda, HM Amin, J You, E Schlette, P Lin - The University of Texas MD Anderson Cancer Center, Houston, TX; Dartmouth Hitchcock Medical Center, Lebanon, NH
Plasma Cell Myeloma: Correlation of Immunophenotype and Genetic Profile in 174 Patients
(1542)
R Setoodeh, L Moscinski, S Razzaque, M Naghashpour - University of South Florida, Tampa, FL; Moffitt Cancer Center, Tampa, FL
Immunophenotypic Profile of Plasma Cells as Assessed by Multi-Color Flow Cytometry: A Comparison between Lymphoplasmacytic Lymphoma and CD45 Positive Myeloma
(1459)
S Konoplev, SA Wang, JL Jorgensen, T Tian, DP Ng, P Lin - The University of Texas MD Anderson Cancer Center, Houston, TX
Plasma Cell Myeloma Evaluation by Flow Cytometric Immunophenotyping: Aberrant Antigen Expression and Correlation with Cytogenetic/FISH Abnormalities
(1434)
AL Husman, M Toscano, KL Chandler, S Lonial, JL Kaufman, KP Mann - Emory University, Atlanta, GA; Winship Cancer Institute of Emory University, Atlanta, GA
Immunophenotypic Profiles of Plasma Cells in Myeloma Precursor Disease Correlate with the Extent of Disease and Risks for Progression
(1368)
KR Calvo, M Corrigan-Cummins, R Costello, P Tembhare, CM Yuan, M Stetler-Stevenson, N Korde, M Kwok, MA Yancey, M Mulquin, O Simakova, Z Adriana, O Landgren, I Maric - NIH CC, Bethesda, MD; NCI, Bethesda, MD
Mature Megakaryocytes Display High-Level CD34 Expression in a Subset of Patients with Myeloma Precursor Disease
(1488)
I Maric, QY Liu, N Korde, O Simakova, K Calvo, A Zingone, R Costello, MA Yancey, P Tembhare, C Yuan, M Stetler- Stevenson, O Landgren - NIH, CC, Bethesda, MD; NIH, Bethesda, MD
Immunophenotypic Heterogeneity of Normal Plasma Cells
(1475)
D Liu, P Lin, Y Hu, L Powers, JL Jorgensen, SA Wang - MD Anderson Cancer Center, Houston, TX
Plasma Cell Myeloma (PCM) with Immunophenotypic Features Transitional between that of Myeloma and Lymphoma
(1350)
D Alapat, D Viswanatha, M Xie, R Lorsbach - UAMS, Little Rock; Mayo Clinic, Rochester; William Beaumont Hospital, Royal Oak
Different Predilection of the Anatomic Distribution of Extra- Lymphoid Involvement in T-Lymphoblastic Lymphoma and B-Lymphoblastic Lymphoma of Childhood
(1594)
M Will, L Yin, X Liang - University of Colorado Denver School of Medicine, Aurora, CO
Distinctive Impacts of Different Lineage of Acute Leukemia on Peripheral Blood and Demographic Parameters in Pediatric Patients
(1539)
YX Schmidt, X Liang - University of Colorado at Denver, Aurora, CO; Childrenīs Hospital Colorado, Aurora, CO
B-Lymphoblastic Leukemia/Lymphoma (B-ALL) with Favorable Cytogenetics: Expression of PAX5 Defines a Subgroup with Poor Overall Survival
(1519)
P Pournazari, A Mansoor, F Kosari, X Jiang, I Auer, T Fourie, J Patel, V Lewis, D Demetrick, D Stewart, M-T Shabani-Rad - University of Calgary/Calgary Laboratory Services (CLS), Calgary, AB, Canada; University of Calgary, Calgary, AB, Canada
Evaluation of Tonsillectomy Specimens for Terminal Deoxynucleotidyl Transferase (TdT) Expression by Immunohistochemistry
(1590)
J Wayne, JW Hussong, R Alsabeh - Cedars-Sinai Medical Center, Los Angeles, CA
Screening for Myelodysplastic Syndromes on Peripheral Blood Using the NEUT-X Parameter on the New Sysmex XE-5000 Analyzer
(1436)
DG Hwang, DM Dorfman, DA Briggs, R Silverio, O Pozdnyakova - Brigham and Womenīs Hospital, Boston, MA; Dana Farber Cancer Institute, Boston, MA; Harvard Medical School, Boston, MA
Bone Marrow Cytogenetics Is Ineffective for Staging Lymphoma and Can Be Reduced by Test Utilization Guideline Implementation
(1454)
RL King, CA Hanson, RP Ketterling, DL Van Dyke, PJ Kurtin - Mayo Clinic, Rochester, MN
Bone Marrow Manifestations of IgG4-Related Disease
(1553)
AR Sohani, A Mahindra, A Khosroshahi, JH Stone, V Deshpande, RP Hasserjian - Massachusetts General Hospital, Boston
Enumeration of CD34 Positive Blasts in Bone Marrow Biopsy Specimens by Digital Image Analysis
(1361)
JM Barroso, Z Wang, K Velazquez, A Dulau-Florea, JZ Gong - Thomas Jefferson University Hospital, Philadelphia, PA
Multi-Vector SIVQ as a Tool for Autonomous Tingible Body Macrophage Localization
(1423)
JA Hipp, G Sharma, JD Hipp, J Cheng, UJ Balis, M Lim, KS Elenitoba-Johnson - University of Michigan, Ann Arbor
Utility of Bone Marrow Examination for Workup of Fever of Unknown Origin in HIV Patients
(1523)
A Quesada, A Tholpady, A Wanger, L Chen - University of Texas Health Science Center at Houston, Houston, TX
Megakaryocytic Hyperplasia Associated with Granulocyte- Colony Stimulating Factor
(1509)
LN Parsons, H Olteanu, SH Kroft, AM Harrington - Medical College of Wisconsin, Milwaukee, WI
Improved Identification of Megakaryoblasts by Flow Cytometry Relative to Immunohistochemistry
(1496)
K Moser, I Bovio, S Hill, SR Tripp, SL Perkins, DW Bahler - University of Utah Health Sciences Center, Salt Lake City, UT; ARUP Laboratories, Salt Lake City, UT
button next to any title to add to Itinerary Planner...
Add
